Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/nanoneuroprotection-and-nanoneurotoxicology/descriptif_3787465
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3787465

Nanoneuroprotection and Nanoneurotoxicology Progress in Brain Research Series

Langue : Anglais
Couverture de l’ouvrage Nanoneuroprotection and Nanoneurotoxicology

Nanoneuroprotection and Nanoneurotoxicology, Volume 245, deals with recent developments in the field of neurotoxicity and neuroprotection using nanobiotechnology for the first time. Chapters in this updated release include Sleep deprivation induced brain pathology and concussive head trauma-Neuroprotective effects of nanowired delivery of drugs and hormones, Nanomedicine in Alzheimer?s Disease: amyloid beta targeting strategy, How traumatic brain injury alters amino acids balance in the central nervous system-Neuroprotection by TiO2 nanowired delivery of drugs and antibodies, Nanowired delivery of DL-3-n-butylphthalide and neuroprotection in concussive head injury, Nanodelivery of drugs and antibodies for superior neuroprotection in Alzheimer?s disease, and more.

1. Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nanowired delivery of cerebrolysin with alpha-melanocyte-stimulating hormone
Aruna Sharma, Dafin F Muresanu, Asya Ozkizilcik, Z Ryan Tian, José Vicente Lafuente, Igor Manzhulo, Herbert Mössler and Hari S Sharma
2. Nanomedicine in Alzheimer’s Disease: Amyloid beta targeting strategy
Giovanni Tosi, Francesca Pederzoli, Daniela Belletti, Maria Angela Vandelli, Flavio Forni, Jason Thomas Duskey and Barbara Ruozi
3. Nanowired delivery of DL-3-n-butylphthalide induces superior neuroprotection in concussive head injury
Feng Niu, Aruna Sharma, Lianyuan Feng, Asya Ozkizilcik, Dafin Muresanu, José Vicente Lafuente, Z Ryan Tian, Ala Nozari and Hari S Sharma
4. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases
Stephen D. Skaper
5. Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer’s disease
Hari Shanker Sharma, Dafin F Muresanu, Rudy J Castellani, Ala Nozari, José Vicente Lafuente, Z Ryan Tian, Asya Ozkizilcik, Igor Manzhulo, Herbert Mössler and Aruna Sharma
6. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson’s disease
Asya Ozkizilcik, Aruna Sharma, José V Lafuente, Dafin Muresanu, Rudy J Castellani, Ala Nozari, Z Ryan Tian, Herbert Moessler and Hari S Sharma
7. Tellurium epigenetic transgenerational effects on behavioral expression of coping behavior in rats
Silvia G. Ratti and Edgardo O. Alvarez
8. Nanodelivery of therapeutic agents in Parkinson’s disease
José Vicente Lafuente, Catalina Requejo and Luisa Ugedo
9. Nanoparticles and neurotoxicity: Dual response of glutamatergic receptors
Ayse Basak Engin and Atilla Engin

Researchers and students of neuroscience, psychology, and the biological sciences interested in nanoneuroprotection and nanoneurotoxicology

  • Highlights recent development in nanopharmacetical research with reference to brain disease
  • Provides new insights on the possible role of nanomaterials and their pronounced effects on CNS injury or repair

Date de parution :

Ouvrage de 321 p.

15.2x22.8 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

227,16 €

Ajouter au panier